Cargando…

Pharmaceutical Cocrystal Formation of Pyrazinamide with 3-Hydroxybenzoic Acid: A Terahertz and Raman Vibrational Spectroscopies Study

Vibrational modes of pyrazinamide (PZA), 3-hydroxybenzoic acid (3-hBA), and their cocrystal were characterized using terahertz time-domain (THz-TDS) and Raman vibrational spectroscopic techniques. In experimental THz spectra, the cocrystal has characteristic absorption bands at around 0.81, 1.47, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiqi, Xue, Jiadan, Hong, Zhi, Du, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384624/
https://www.ncbi.nlm.nih.gov/pubmed/30704029
http://dx.doi.org/10.3390/molecules24030488
_version_ 1783397021180231680
author Wang, Qiqi
Xue, Jiadan
Hong, Zhi
Du, Yong
author_facet Wang, Qiqi
Xue, Jiadan
Hong, Zhi
Du, Yong
author_sort Wang, Qiqi
collection PubMed
description Vibrational modes of pyrazinamide (PZA), 3-hydroxybenzoic acid (3-hBA), and their cocrystal were characterized using terahertz time-domain (THz-TDS) and Raman vibrational spectroscopic techniques. In experimental THz spectra, the cocrystal has characteristic absorption bands at around 0.81, 1.47, and 1.61 THz, respectively, meanwhile the raw materials are absolutely different in this region. Raman spectra also show similar results about differences between the cocrystal and corresponding starting parent materials. Density functional theory (DFT) was used to simulate both optimized structures and vibrational modes of the cocrystal formed between PZA and 3-hBA. The vibrational modes of such cocrystal are assigned through comparing the simulation DFT frequency results with experimental vibrational spectra. The calculation of the theoretical THz spectrum shows that the hydrogen bonding effect established between H11–N12–H13 and the carboxyl group -COOH makes contributions to the formation of absorption peaks in 0.49, 0.62, 0.83, and 1.61 THz, which agrees pretty well with experimental results. The theoretical Raman result also matches well with experimental observations. The results provide a fundamental benchmark for the study of pharmaceutical cocrystal formation and also inter-molecular hydrogen bonding interactions between active pharmaceutical ingredients and various cocrystal coformers based on Raman and terahertz vibrational spectroscopic techniques combined with theoretical simulations.
format Online
Article
Text
id pubmed-6384624
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63846242019-02-23 Pharmaceutical Cocrystal Formation of Pyrazinamide with 3-Hydroxybenzoic Acid: A Terahertz and Raman Vibrational Spectroscopies Study Wang, Qiqi Xue, Jiadan Hong, Zhi Du, Yong Molecules Article Vibrational modes of pyrazinamide (PZA), 3-hydroxybenzoic acid (3-hBA), and their cocrystal were characterized using terahertz time-domain (THz-TDS) and Raman vibrational spectroscopic techniques. In experimental THz spectra, the cocrystal has characteristic absorption bands at around 0.81, 1.47, and 1.61 THz, respectively, meanwhile the raw materials are absolutely different in this region. Raman spectra also show similar results about differences between the cocrystal and corresponding starting parent materials. Density functional theory (DFT) was used to simulate both optimized structures and vibrational modes of the cocrystal formed between PZA and 3-hBA. The vibrational modes of such cocrystal are assigned through comparing the simulation DFT frequency results with experimental vibrational spectra. The calculation of the theoretical THz spectrum shows that the hydrogen bonding effect established between H11–N12–H13 and the carboxyl group -COOH makes contributions to the formation of absorption peaks in 0.49, 0.62, 0.83, and 1.61 THz, which agrees pretty well with experimental results. The theoretical Raman result also matches well with experimental observations. The results provide a fundamental benchmark for the study of pharmaceutical cocrystal formation and also inter-molecular hydrogen bonding interactions between active pharmaceutical ingredients and various cocrystal coformers based on Raman and terahertz vibrational spectroscopic techniques combined with theoretical simulations. MDPI 2019-01-30 /pmc/articles/PMC6384624/ /pubmed/30704029 http://dx.doi.org/10.3390/molecules24030488 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Qiqi
Xue, Jiadan
Hong, Zhi
Du, Yong
Pharmaceutical Cocrystal Formation of Pyrazinamide with 3-Hydroxybenzoic Acid: A Terahertz and Raman Vibrational Spectroscopies Study
title Pharmaceutical Cocrystal Formation of Pyrazinamide with 3-Hydroxybenzoic Acid: A Terahertz and Raman Vibrational Spectroscopies Study
title_full Pharmaceutical Cocrystal Formation of Pyrazinamide with 3-Hydroxybenzoic Acid: A Terahertz and Raman Vibrational Spectroscopies Study
title_fullStr Pharmaceutical Cocrystal Formation of Pyrazinamide with 3-Hydroxybenzoic Acid: A Terahertz and Raman Vibrational Spectroscopies Study
title_full_unstemmed Pharmaceutical Cocrystal Formation of Pyrazinamide with 3-Hydroxybenzoic Acid: A Terahertz and Raman Vibrational Spectroscopies Study
title_short Pharmaceutical Cocrystal Formation of Pyrazinamide with 3-Hydroxybenzoic Acid: A Terahertz and Raman Vibrational Spectroscopies Study
title_sort pharmaceutical cocrystal formation of pyrazinamide with 3-hydroxybenzoic acid: a terahertz and raman vibrational spectroscopies study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384624/
https://www.ncbi.nlm.nih.gov/pubmed/30704029
http://dx.doi.org/10.3390/molecules24030488
work_keys_str_mv AT wangqiqi pharmaceuticalcocrystalformationofpyrazinamidewith3hydroxybenzoicacidaterahertzandramanvibrationalspectroscopiesstudy
AT xuejiadan pharmaceuticalcocrystalformationofpyrazinamidewith3hydroxybenzoicacidaterahertzandramanvibrationalspectroscopiesstudy
AT hongzhi pharmaceuticalcocrystalformationofpyrazinamidewith3hydroxybenzoicacidaterahertzandramanvibrationalspectroscopiesstudy
AT duyong pharmaceuticalcocrystalformationofpyrazinamidewith3hydroxybenzoicacidaterahertzandramanvibrationalspectroscopiesstudy